| Overview |
| bs-13561R |
| ZADH1 Polyclonal Antibody |
| WB, ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC), ICC |
| Human, Mouse, Rat, Dog, Cow, Sheep, Pig, Horse, Rabbit |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human ZADH1 |
| 251-351/351 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 145482 |
| Cytoplasm |
| 15 oxoprostaglandin 13 reductase; 15 oxoprostaglandin delta 13 reductase; 15-oxoprostaglandin 13-reductase; DKFZp686P10120; FLJ39091; FLJ99229; PGR 2; PGR2; PRG-2; Prostaglandin reductase 2; PTGR 2; PTGR2; PTGR2_HUMAN; Zinc binding alcohol dehydrogenase domain containing 1; Zinc binding alcohol dehydrogenase domain containing protein 1; Zinc-binding alcohol dehydrogenase domain-containing protein 1. |
| Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-keto-PGE1, 15-keto-PGE2, 15-keto-PGE1-alpha and 15-keto-PGE2-alpha with highest activity towards 15-keto-PGE2. Overexpression represses transcriptional activity of PPARG and inhibits adipocyte differentiation. |
| Application Dilution |
| WB |
1:300-5000 |
| ELISA |
1:500-1000 |
| IHC-P |
1:200-400 |
| IHC-F |
1:100-500 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
| ICC |
1:100-500 |
Powered by Bioz